-
Survival Model Uncertainty in Economic Modeling: Evaluating Bootstrap and Cholesky Decomposition Methods
Sep 9, 2025, 16:22 PM -
Assessing the Environmental Value of Semaglutide: Reduction in GHG Emissions Resulting From the Treatment of Obese Individuals With Type 2 Diabetes
Sep 9, 2025, 16:22 PM -
Incorporating Equity-of-Access Into Health Economic Evaluations: Surgical Task-Shifting for C-Sections in Sierra Leone
Sep 9, 2025, 16:22 PM -
Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions
Sep 9, 2025, 16:22 PM -
EQ-5D Utility Trends in NMOSD: Impact of Time and Disability
Sep 9, 2025, 16:22 PM -
A Model-Based Estimation of Productivity-Adjusted Life Years Due to Depression in Germany
Sep 9, 2025, 16:22 PM -
Real-World Evidence Study on Healthcare Resource Utilization (HCRU) Among Cancer Patients in the Helsinki and Uusimaa (HUS) Region, Finland
Sep 9, 2025, 16:22 PM -
Development and Application of a JCA-Alignment Checklist for Early Economic Modeling in EU HTA
Sep 9, 2025, 16:22 PM -
Comparative Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole for the Treatment of Invasive Aspergillosis in Algerian Hospital Setting
Sep 9, 2025, 16:22 PM -
Investigating the Importance of EQ-5D Domains and Two Bolt-on Items: How Do the Preferences of People With Acute Leukemia Differ From the General Population?
Sep 9, 2025, 16:22 PM -
Use of Big Data to Assess Dyslipidemia Management in Greece: Real-World Insights From the National Healthcare Payer
Sep 9, 2025, 16:22 PM -
Cardioprotective Medication Use Among Diabetic Patients With ASCVD in Qatar's Primary Care Setting
Sep 9, 2025, 16:22 PM -
Healthcare Burden Among Patients With Chronic Inflammatory Demyelinating Polyneuropathy: A Targeted Literature Review
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Standard-Dose vs. High-Dose Influenza Vaccination in Adults Aged ≥65 Years in Italy
Sep 9, 2025, 16:22 PM -
Mapping Anatomic Pathology Laboratories of Public Hospitals in Greece: Units, Infrastructure, Personnel, and Workload Estimation
Sep 9, 2025, 16:22 PM -
Medication Use in Indolent Systemic Mastocytosis (ISM) in Germany Prior to Avapritinib EMA Approval
Sep 9, 2025, 16:22 PM -
Including Decision Uncertainty About the Clinically Minimal Important Difference: Shifting From Risk Aversion to Risk Awareness in Drug Reimbursement Processes
Sep 9, 2025, 16:22 PM -
Review of Rare Disease Policy Developments in Europe and Türkiye 2020-2025 in the Context of Innovative Orphan Drugs
Sep 9, 2025, 16:22 PM -
Transfusion Healthcare Resource Utilization and Associated Impact of Quality of Life Among Patients With Myelofibrosis and Anemia: A Multinational Real-World Survey
Sep 9, 2025, 16:22 PM -
Are Economic Models in R That Shiny? Making Cost-Effectiveness Models Shinier by Integrating Artificial Intelligence Applications
Sep 9, 2025, 16:22 PM
